{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T01:07:06Z","timestamp":1782608826368,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,8]]},"DOI":"10.7759\/cureus.66420","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T08:09:09Z","timestamp":1723104549000},"source":"Crossref","is-referenced-by-count":2,"title":["Strategies for Cardiovascular Disease Prevention in Type 1 Diabetes: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Abhinav","family":"Ahuja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourya","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Type 1 diabetes","author":"Lucier J","year":"2024","unstructured":"Lucier J, Weinstock RS. Type 1 diabetes. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"32","author":"American Diabetes Association","year":"2009","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009, 32:S62-7. 10.2337\/dc09-S062","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v5.i4.444","article-title":"Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?","volume":"5","author":"Mart\u00edn-Tim\u00f3n I","year":"2014","unstructured":"Mart\u00edn-Tim\u00f3n I, Sevillano-Collantes C, Segura-Galindo A, Del Ca\u00f1izo-G\u00f3mez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?. World J Diabetes. 2014, 5:444-70. 10.4239\/wjd.v5.i4.444","journal-title":"World J Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081798","article-title":"Cardiovascular disease in type 1 diabetes mellitus: epidemiology and management of cardiovascular risk","volume":"10","author":"Colom C","year":"2021","unstructured":"Colom C, Rull A, Sanchez-Quesada JL, P\u00e9rez A. Cardiovascular disease in type 1 diabetes mellitus: epidemiology and management of cardiovascular risk. J Clin Med. 2021, 10:1798. 10.3390\/jcm10081798","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45835","article-title":"Cardiovascular complications of diabetes: from microvascular to macrovascular pathways","volume":"15","author":"Zakir M","year":"2023","unstructured":"Zakir M, Ahuja N, Surksha MA, et al.. Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus. 2023, 15:e45835. 10.7759\/cureus.45835","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced glycation end products and diabetic complications","volume":"18","author":"Singh VP","year":"2014","unstructured":"Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014, 18:1-14. 10.4196\/kjpp.2014.18.1.1","journal-title":"Korean J Physiol Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3706508","article-title":"Role of c-reactive protein in diabetic inflammation","volume":"2022","author":"Stanimirovic J","year":"2022","unstructured":"Stanimirovic J, Radovanovic J, Banjac K, et al.. Role of c-reactive protein in diabetic inflammation. Mediators Inflamm. 2022, 2022:508. 10.1155\/2022\/3706508","journal-title":"Mediators Inflamm"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco F","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010, 107:1058-70. 10.1161\/CIRCRESAHA.110.223545","journal-title":"Circ Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01137-x","article-title":"Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine","volume":"19","author":"Tecce N","year":"2020","unstructured":"Tecce N, Masulli M, Lupoli R, et al.. Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine. Cardiovasc Diabetol. 2020, 19:166. 10.1186\/s12933-020-01137-x","journal-title":"Cardiovasc Diabetol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001040","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association","volume":"145","author":"Joseph JJ","year":"2022","unstructured":"Joseph JJ, Deedwania P, Acharya T, et al.. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation. 2022, 145:e722-59. 10.1161\/CIR.0000000000001040","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000034","article-title":"Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association","volume":"130","author":"de Ferranti SD","year":"2014","unstructured":"de Ferranti SD, de Boer IH, Fonseca V, et al.. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation. 2014, 130:1110-30. 10.1161\/CIR.0000000000000034","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i13.1246","article-title":"Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research","volume":"6","author":"Leon BM","year":"2015","unstructured":"Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015, 6:1246-58. 10.4239\/wjd.v6.i13.1246","journal-title":"World J Diabetes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193034","article-title":"Effect of glucose levels on cardiovascular risk","volume":"11","author":"Poznyak AV","year":"2022","unstructured":"Poznyak AV, Litvinova L, Poggio P, Sukhorukov VN, Orekhov AN. Effect of glucose levels on cardiovascular risk. Cells. 2022, 11:3034. 10.3390\/cells11193034","journal-title":"Cells"},{"key":"ref14","article-title":"Cardiovascular risk reduction in youth with diabetes - opportunities and challenges","author":"Shah AS","year":"2000","unstructured":"Shah AS, Wilson DP. Cardiovascular risk reduction in youth with diabetes - opportunities and challenges. Endotext. Feingold KR, Anawalt B, Blackman MR (ed): MDText.com, Inc., South Dartmouth, MA; 2000."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-020-01336-6","article-title":"Dyslipidemia in pediatric type 2 diabetes mellitus","volume":"20","author":"Sunil B","year":"2020","unstructured":"Sunil B, Ashraf AP. Dyslipidemia in pediatric type 2 diabetes mellitus. Curr Diab Rep. 2020, 20:53. 10.1007\/s11892-020-01336-6","journal-title":"Curr Diab Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1559827618812395","article-title":"Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease","volume":"13","author":"Rippe JM","year":"2019","unstructured":"Rippe JM. Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease. Am J Lifestyle Med. 2019, 13:204-12. 10.1177\/1559827618812395","journal-title":"Am J Lifestyle Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168393","article-title":"The role of glycemic variability in cardiovascular disorders","volume":"22","author":"Alfieri V","year":"2021","unstructured":"Alfieri V, Myasoedova VA, Vinci MC, et al.. The role of glycemic variability in cardiovascular disorders. Int J Mol Sci. 2021, 22:8393. 10.3390\/ijms22168393","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910192","article-title":"Sex-related differences in cardiovascular disease risk profile in children and adolescents with type 1 diabetes","volume":"22","author":"Smigoc Schweiger D","year":"2021","unstructured":"Smigoc Schweiger D, Battelino T, Groselj U. Sex-related differences in cardiovascular disease risk profile in children and adolescents with type 1 diabetes. Int J Mol Sci. 2021, 22:192. 10.3390\/ijms221910192","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.genm.2012.05.003","article-title":"Sex differences in cardiovascular disease risk in adolescents with type 1 diabetes","volume":"9","author":"Krishnan S","year":"2012","unstructured":"Krishnan S, Fields DA, Copeland KC, Blackett PR, Anderson MP, Gardner AW. Sex differences in cardiovascular disease risk in adolescents with type 1 diabetes. Gend Med. 2012, 9:251-8. 10.1016\/j.genm.2012.05.003","journal-title":"Gend Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-020-01348-2","article-title":"Do women with diabetes need more intensive action for cardiovascular reduction than men with diabetes?","volume":"20","author":"Harreiter J","year":"2020","unstructured":"Harreiter J, Fadl H, Kautzky-Willer A, Simmons D. Do women with diabetes need more intensive action for cardiovascular reduction than men with diabetes?. Curr Diab Rep. 2020, 20:61. 10.1007\/s11892-020-01348-2","journal-title":"Curr Diab Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144928","article-title":"The impact of diabetes mellitus on cardiovascular risk onset in children and adolescents","volume":"21","author":"Pastore I","year":"2020","unstructured":"Pastore I, Bolla AM, Montefusco L, et al.. The impact of diabetes mellitus on cardiovascular risk onset in children and adolescents. Int J Mol Sci. 2020, 21:4928. 10.3390\/ijms21144928","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.696499","article-title":"Preventing cardiovascular complications in type 1 diabetes: the need for a lifetime approach","volume":"9","author":"Chiesa ST","year":"2021","unstructured":"Chiesa ST, Marcovecchio ML. Preventing cardiovascular complications in type 1 diabetes: the need for a lifetime approach\r\n. Front Pediatr. 2021, 9:499. 10.3389\/fped.2021.696499","journal-title":"Front Pediatr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa015","article-title":"Risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry","volume":"105","author":"Shah VN","year":"2020","unstructured":"Shah VN, Bailey R, Wu M, et al.. Risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry. J Clin Endocrinol Metab. 2020, 105:e2032-8. 10.1210\/clinem\/dgaa015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2563","article-title":"Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus","volume":"287","author":"The Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2002","unstructured":"The Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002, 287:2563-9. 10.1001\/jama.287.19.2563","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43882","article-title":"Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes","volume":"15","author":"Jyotsna F","year":"2023","unstructured":"Jyotsna F, Ahmed A, Kumar K, et al.. Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes. Cureus. 2023, 15:e43882. 10.7759\/cureus.43882","journal-title":"Cureus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.91202","article-title":"Screening for coronary artery disease in patients with type 2 diabetes mellitus: an evidence-based review","volume":"16","author":"Chopra S","year":"2012","unstructured":"Chopra S, Peter S. Screening for coronary artery disease in patients with type 2 diabetes mellitus: an evidence-based review. Indian J Endocrinol Metab. 2012, 16:94-101. 10.4103\/2230-8210.91202","journal-title":"Indian J Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/nu5093646","article-title":"Nutritional recommendations for cardiovascular disease prevention","volume":"5","author":"Eilat-Adar S","year":"2013","unstructured":"Eilat-Adar S, Sinai T, Yosefy C, Henkin Y. Nutritional recommendations for cardiovascular disease prevention. Nutrients. 2013, 5:3646-83. 10.3390\/nu5093646","journal-title":"Nutrients"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2234","article-title":"Dietary and nutritional approaches for prevention and management of type 2 diabetes","volume":"361","author":"Forouhi NG","year":"2018","unstructured":"Forouhi NG, Misra A, Mohan V, Taylor R, Yancy W. Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ. 2018, 361:234. 10.1136\/bmj.k2234","journal-title":"BMJ"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8020253","article-title":"Cardiovascular health benefits of exercise training in persons living with type 1 diabetes: a systematic review and meta-analysis","volume":"8","author":"Wu N","year":"2019","unstructured":"Wu N, Bredin SS, Guan Y, et al.. Cardiovascular health benefits of exercise training in persons living with type 1 diabetes: a systematic review and meta-analysis. J Clin Med. 2019, 8:253. 10.3390\/jcm8020253","journal-title":"J Clin Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33475","article-title":"Role of physical activity on mental health and well-being: a review","volume":"15","author":"Mahindru A","year":"2023","unstructured":"Mahindru A, Patil P, Agrawal V. Role of physical activity on mental health and well-being: a review. Cureus. 2023, 15:e33475. 10.7759\/cureus.33475","journal-title":"Cureus"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2020.02.47","article-title":"Cardiovascular risk of smoking and benefits of smoking cessation","volume":"12","author":"Gallucci G","year":"2020","unstructured":"Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020, 12:3866-76. 10.21037\/jtd.2020.02.47","journal-title":"J Thorac Dis"},{"key":"ref32","article-title":"Smoking Cessation: A Report of the Surgeon General","author":"United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health","year":"2020","unstructured":"United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking Cessation: A Report of the Surgeon General. US Department of Health and Human Services, Washington, DC; 2020."},{"key":"ref33","article-title":"Insulin - pharmacology, therapeutic regimens and principles of intensive insulin therapy","author":"Donnor T","year":"2000","unstructured":"Donnor T, Sarkar S. Insulin - pharmacology, therapeutic regimens and principles of intensive insulin therapy. Endotext. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText.com, Inc., South Dartmouth, MA; 2000."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-019-00743-7","article-title":"Insulin therapy in adults with type 1 diabetes mellitus: a narrative review","volume":"11","author":"Jane\u017e A","year":"2020","unstructured":"Jane\u017e A, Guja C, Mitrakou A, et al.. Insulin therapy in adults with type 1 diabetes mellitus: a narrative review. Diabetes Ther. 2020, 11:387-409. 10.1007\/s13300-019-00743-7","journal-title":"Diabetes Ther"},{"key":"ref35","article-title":"Monitoring technologies - continuous glucose monitoring, mobile technology, biomarkers of glycemic control","author":"Reddy N","year":"2000","unstructured":"Reddy N, Verma N, Dungan K. Monitoring technologies - continuous glucose monitoring, mobile technology, biomarkers of glycemic control. Endotext. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText.com, Inc., South Dartmouth, MA; 2000."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.86982","article-title":"Management of diabetic hypertensives","volume":"15","author":"Ganesh J","year":"2011","unstructured":"Ganesh J, Viswanathan V. Management of diabetic hypertensives. Indian J Endocrinol Metab. 2011, 15:S374-9. 10.4103\/2230-8210.86982","journal-title":"Indian J Endocrinol Metab"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-9-60","article-title":"Renal protection in diabetes: lessons from ONTARGET","volume":"9","author":"Ritz E","year":"2010","unstructured":"Ritz E, Schmieder RE, Pollock CA. Renal protection in diabetes: lessons from ONTARGET. Cardiovasc Diabetol. 2010, 9:60. 10.1186\/1475-2840-9-60","journal-title":"Cardiovasc Diabetol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000551","article-title":"Lipid management for cardiovascular risk reduction in type 1 diabetes","volume":"27","author":"Tell S","year":"2020","unstructured":"Tell S, Nadeau KJ, Eckel RH. Lipid management for cardiovascular risk reduction in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2020, 27:207-14. 10.1097\/MED.0000000000000551","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v9.i2.76","article-title":"PCSK9 inhibitors: a new era of lipid lowering therapy","volume":"9","author":"Chaudhary R","year":"2017","unstructured":"Chaudhary R, Garg J, Shah N, Sumner A. PCSK9 inhibitors: a new era of lipid lowering therapy. World J Cardiol. 2017, 9:76-91. 10.4330\/wjc.v9.i2.76","journal-title":"World J Cardiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15221","article-title":"Antiplatelet therapy in cardiovascular disease: current status and future directions","volume":"88","author":"Passacquale G","year":"2022","unstructured":"Passacquale G, Sharma P, Perera D, Ferro A. Antiplatelet therapy in cardiovascular disease: current status and future directions. Br J Clin Pharmacol. 2022, 88:2686-99. 10.1111\/bcp.15221","journal-title":"Br J Clin Pharmacol"},{"key":"ref41","article-title":"Platelets, coagulation, and antithrombotic therapy in diabetes","author":"Parker WAE","year":"2000","unstructured":"Parker WAE, Storey RF, Ajjan RA. Platelets, coagulation, and antithrombotic therapy in diabetes. Endotext. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText.com, Inc., South Dartmouth, MA; 2000."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1322148","article-title":"Verapamil chronicles: advances from cardiovascular to pancreatic \u03b2-cell protection","volume":"14","author":"Arefanian H","year":"2023","unstructured":"Arefanian H, Koti L, Sindhu S, Ahmad R, Al Madhoun A, Al-Mulla F. Verapamil chronicles: advances from cardiovascular to pancreatic \u03b2-cell protection. Front Pharmacol. 2023, 14:1-12. 10.3389\/fphar.2023.1322148","journal-title":"Front Pharmacol"},{"key":"ref43","unstructured":"Transforming diabetes management. the adoption of technology as a game changer in diabetes care. (2023). Accessed: February 3, 2024: https:\/\/genintmedcommunity.springernature.com\/posts\/transforming-diabetes-management-the-adoption-of-technology-as-a-...."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/genes8030101","article-title":"The diabetes-linked transcription factor PAX4: from gene to functional consequences","volume":"8","author":"Lorenzo PI","year":"2017","unstructured":"Lorenzo PI, Ju\u00e1rez-Vicente F, Cobo-Vuilleumier N, Garc\u00eda-Dom\u00ednguez M, Gauthier BR. The diabetes-linked transcription factor PAX4: from gene to functional consequences. Genes (Basel). 2017, 8:101. 10.3390\/genes8030101","journal-title":"Genes (Basel)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16030332","article-title":"Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare","volume":"16","author":"Marques L","year":"2024","unstructured":"Marques L, Costa B, Pereira M, et al.. Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics. 2024, 16:332. 10.3390\/pharmaceutics16030332","journal-title":"Pharmaceutics"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1177\/26335565231165966","article-title":"The multidisciplinary team in diagnosing and treatment of patients with diabetes and comorbidities: a scoping review","volume":"13","author":"Andersen JD","year":"2023","unstructured":"Andersen JD, Jensen MH, Vestergaard P, Jensen V, Hejlesen O, Hangaard S. The multidisciplinary team in diagnosing and treatment of patients with diabetes and comorbidities: a scoping review. J Multimorb Comorb. 2023, 13:2633. 10.1177\/26335565231165966","journal-title":"J Multimorb Comorb"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302041","article-title":"Self-management: a comprehensive approach to management of chronic conditions","volume":"104","author":"Grady PA","year":"2014","unstructured":"Grady PA, Gough LL. Self-management: a comprehensive approach to management of chronic conditions. Am J Public Health. 2014, 104:e25-31. 10.2105\/AJPH.2014.302041","journal-title":"Am J Public Health"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.sintl.2021.100117","article-title":"Telemedicine for healthcare: capabilities, features, barriers, and applications","volume":"2","author":"Haleem A","year":"2021","unstructured":"Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: capabilities, features, barriers, and applications. Sens Int. 2021, 2:100117. 10.1016\/j.sintl.2021.100117","journal-title":"Sens Int"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.113749","article-title":"Barriers and solutions to diabetes management: an Indian perspective","volume":"17","author":"Wangnoo SK","year":"2013","unstructured":"Wangnoo SK, Maji D, Das AK, et al.. Barriers and solutions to diabetes management: an Indian perspective. Indian J Endocrinol Metab. 2013, 17:594-601. 10.4103\/2230-8210.113749","journal-title":"Indian J Endocrinol Metab"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32833a46a7","article-title":"Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention","volume":"22","author":"Borus JS","year":"2010","unstructured":"Borus JS, Laffel L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr. 2010, 22:405-11. 10.1097\/MOP.0b013e32833a46a7","journal-title":"Curr Opin Pediatr"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029652","article-title":"Socioeconomic status and cardiovascular outcomes: challenges and interventions","volume":"137","author":"Schultz WM","year":"2018","unstructured":"Schultz WM, Kelli HM, Lisko JC, et al.. Socioeconomic status and cardiovascular outcomes: challenges and interventions. Circulation. 2018, 137:2166-78. 10.1161\/CIRCULATIONAHA.117.029652","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/281810-strategies-for-cardiovascular-disease-prevention-in-type-1-diabetes-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T08:09:15Z","timestamp":1723104555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/281810-strategies-for-cardiovascular-disease-prevention-in-type-1-diabetes-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.66420","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,8]]}}}